A Contactless Edge-AI Prototype for Simulated Apnea-like Respiratory Suppression and Motion Artifact Detection Using 60 GHz FMCW Radar

Sleep-related respiratory disturbances are difficult to monitor continuously outside specialized laboratories because conventional polysomnography is resource-intensive and intrusive. This study presents a contactless edge-AI engineering prototype for detecting controlled voluntary respiratory-motion suppression and motion artifacts using a 60 GHz frequency-modulated continuous-wave radar. The system integrates a 60 GHz radar front end, lightweight local preprocessing, an INT8 one-dimensional convolutional neural network deployed on the Analog Devices MAX78000 CNN accelerator (Analog Devices Thailand, Chon Buri, Thailand), and an event-driven Raspberry Pi Zero 2W gateway for alert transmission. Evaluation was performed using a controlled healthy-volunteer dataset consisting of normal breathing, voluntary breath-holding-induced respiratory suppression, and deliberate motion artifact. The final valid test set contained 270 technically valid 30 s windows balanced across the three classes. The INT8 model achieved an overall accuracy of 92.6% (95% confidence interval: 88.8–95.2%), with a macro-averaged precision, recall, and F1-score of 92.6%, 92.6%, and 92.5%, respectively. Active CNN inference on the MAX78000 consumed 0.152 ± 0.011 mJ and was completed in 5.20 ± 0.11 ms, corresponding to approximately 280-fold lower active inference energy than Python 3.14.6/TensorFlow Lite 2.21.0-based execution on the Raspberry Pi Zero 2W. These results demonstrate the feasibility of privacy-aware, low-power respiratory-pattern classification at the edge. However, the study should be interpreted strictly as an engineering proof-of-concept based on controlled voluntary breathing and movement tasks in healthy volunteers. It is not a clinically validated apnea or obstructive sleep apnea detection system and did not include polysomnography, oxygen saturation measurement, airflow sensing, sleep staging, or diagnosed patient cohorts.